181 bipartisan delegates urge enforcement of 340B program

In a letter to HHS supported by HANYS, lawmakers, led in part by Rep. Katko, urged the agency to take enforcement action on drug companies withholding 340B discounts from safety net providers. “Every day that drug manufacturers violate their obligation to provide these discounted drugs,” the letter said, “vulnerable communities, federal grantees, and safety net health care providers are deprived of resources Congress intended to provide.” We thank the 12 New York delegation members who signed the letter at HANYS’ request and continue to advocate on behalf of our members who rely on the 340B program to serve their communities.